Interestingly, when the CD24 positivity was used together with another immune prognostic marker (CD3+ TIL status), a subgroup of NPC tumors that were positive for CD24 expression and had low CD3+ TIL in the tumor microenvironment had the worst DFS, MFS and OS. The gene discussed is CD24; the disease is neoplasm.